Earth to be hit by powerful shockwave in just HOURS after giant 'claw-shaped' hole bursts through the sun
A giant hole has ripped open on the sun, blasting Earth with a high-speed stream of charged particles that could trigger power disruptions.
Officials warned that the solar wind is expected to strike Earth Friday causing a G2-level geomagnetic storm that is considerate moderate on a scale from G1 to G5.
However, it is still powerful enough to damage transformers in high-latitude power systems, affect satellite operations, and cause radio blackouts.
'Weak power grid fluctuations can occur,' officials share in a Friday update, noting that electricity has weakened around Michigan as of this morning.
A geomagnetic storm is a temporary disturbance of Earth's magnetic field caused by a massive eruption of charged plasma from the sun's outermost layer.
The official space weather forecast showed G-2 levels are expected to linger into Saturday, but decrease to a G1 storm by Sunday.
The solar activity could also send stunning northern lights as far south as Maine and Michigan.
The solar storm comes as scientists recently warned that humanity is not prepared for extreme space weather.
The colossal claw-shaped opening, known as a coronal hole, is the source of what's known as a Coronal Hole High-Speed Stream (CH HSS), a fast-moving flow of solar wind now headed straight for Earth.
The wind is currently traveling at hundreds of miles per second, faster than Earth's magnetic field.
As the stream catches up to slower solar wind ahead of it, it may create a Co-Rotating Interaction Region (CIR), a shockwave-like effect that can intensify the storm by compressing Earth's magnetic field.
This can lead to a range of effects: slight changes in satellite orbits, glitches in onboard instruments, and disruptions to polar flight navigation that relies on radio signals.
GPS services may also be affected, causing timing errors or location drift, especially near the poles or at high altitudes.
These disturbances are more common and more intense during solar maximum, the most active phase of the sun's 11-year cycle, when solar flares, sunspots, and coronal mass ejections peak.
Sunspots are dark areas on the sun where it's extra active, and solar flares are sudden bursts of energy from those spots.
Coronal mass ejections are huge clouds of charged particles the sun blasts into space, which can affect Earth's magnetic field.
During geomagnetic storms, solar particles strike Earth's magnetic field, some are directed to the planet's poles, where they collide with the gases in the atmosphere creating auroras.
On Saturday, auroras could be visible as far south as 55 degrees latitude, including parts of the northern US from New York to Idaho, depending on weather and light conditions.
The best views are expected further north, particularly in Canada.
On average, Earth experiences about 360 G2 level storms during the single solar cycle.
The G2 storm, the one recorded in September 2018, lasted for about four hours, with lingering weaker disturbances, classified as G1-level, before and after the main event.
Scientists say the same coronal hole faced Earth almost exactly a year ago, from June 4–5, 2024, and triggered a sustained G2-level storm.
In May, experts revealed they conducted extreme space weather scenario and found Earth may not survive.
They conducted a 'solar storm emergency drill', simulating what would happen if a major geomagnetic storm hit our planet.
Results showed power grids failed, blackouts were triggered and communication broke down across the US.
The exercise ran four simulations of geomagnetic storms of different severities, which is is a temporary disturbance of Earth's magnetic field caused by a massive eruption of charged plasma from the sun's outermost layer.
One scenario included a 'solar superstorm', strong enough cause an 'internet apocalypse,' resulting in power grid disruptions across the entire US with the eastern seaboard experiencing blackouts, which lasted for weeks.
Not only were power grids impacted, but railways and pipelines were also knocked offline, causing mass disruptions of travel and dramatic price increases of gas.
Scientists are now calling for a whole-of-government planning approach, arguing it will be critical for protecting America from cosmic disaster.
That would include deploying more satellites to monitor space weather, enhance real-time data collection to improve forecasting models, and provide earlier warnings.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medical News Today
an hour ago
- Medical News Today
Celiac disease: Is an easier way to diagnose it on the horizon?
Could a blood test diagnose celiac disease without the need to trigger symptoms? Image credit: Alvaro Lavin/Stocksy. Celiac disease has to do with an abnormal immune response of the body to gluten. Experts are interested in the best ways to test for celiac disease. A recent study discovered that a blood test called WBAIL-2 could aid in diagnosing celiac disease and even contribute to biopsy-free diagnosis. Celiac disease occurs when someone's immune system responds abnormally to gluten. Efforts to improve celiac disease diagnosis are ongoing. A study recently published in Gastroenterology evaluated the effectiveness of using a blood test that measures the cytokine interleukin-2 to diagnose celiac disease. The study's results indicated that the test to be highly effective for celiac disease diagnosis, even for people following a gluten-free diet. The test could offer another option to help with celiac disease diagnosis — importantly, one that would not require triggering symptoms to confirm the disease. The authors of the current study note that there is often a delay or lack of diagnosis when it comes to celiac disease. Diagnosis usually involves people having to eat gluten and get biopsies of the small intestine. Celiac disease also has to do with the response of a group of immune cells, CD4+ gluten-specific T-cells. For this study, researchers wanted to determine if the use of a blood test that measures interleukin-2 — a protein produced by some T-cells — release could help to accurately diagnose celiac disease. This research involved a total of 181 adult participants between 18 and 75 years old. Of these participants, 88 had celiac disease, and others were controls. Among controls, 32 participants had a non-celiac gluten sensitivity and were on a gluten-free diet. The rest were healthy controls who did not have gluten sensitivity. All participants provided blood samples, and researchers collected data on medications and medical history. A subset of participants, including healthy controls, participants with non-celiac gluten sensitivity, and treated celiac disease, went on a gluten-free diet for four weeks or more and then consumed gluten for 'a single-dose open-label gluten challenge.' Some participants with treated celiac disease also did an oral gluten challenge that lasted 3 days. If participants underwent the oral gluten challenge, they used diaries to keep track of their symptoms. Researchers utilized a blood test called a WBAIL-2 assay, which measures the release of interleukin-2 in vitro after adding gluten peptides. In general, the test was able to effectively confirm celiac disease, with higher concentrations and fold change of interleukin-2 in participants who had celiac disease. However, the results were less sensitive for participants with a certain, less common genotype. Analysis results also found that the WBAIL-2 assay correlated with age and the number of years participants had been following a gluten-free diet. Next, researchers tested participants' serum levels of interleukin-2 after they did an oral gluten challenge. The levels of interleukin-2 were higher for participants with celiac disease following the oral gluten challenge. Researchers also found these levels 'positively correlated with the WBAIL-2 results.' So, if the levels of interleukin-2 were elevated on one test, they were also elevated on the other. They also tested how the WBAIL-2 results related to the presence of gluten-specific T cells, which were higher among participants with celiac disease. They did find that the presence of these cells, as well as activated versions of these cells, correlated with the WBAIL-2 test. The researchers further found that gluten-specific T cells, activated versions of these cells, and WBAIL-2 increased after participants underwent a gluten challenge. However, one participant had lower gluten-specific CD4+ T cells and a lower WBAIL-2 test on day six. Researchers also looked at treated celiac disease participants and how the tests related to their symptoms after gluten exposure. When it came to gluten-specific T-cells, their frequency was higher in participants who experienced vomiting. The measurement of serum interleukin-2 following the gluten tolerance test was also elevated, as was the WBAIL-2 level. The WBAIL-2 level was also increased greatly for one participant who did not experience vomiting but did report severe tiredness. Further analysis also suggested that activated gluten-specific CD4+ T cells are the cells that lead to gluten-induced production of interleukin-2. The results suggest that the WBAIL-2 assay can help with celiac disease diagnosis, even when people are already following a gluten-free diet. There are some limitations to this study. For one thing, it was performed out of one area, most participants were female, and there were strict inclusion criteria, so it has a limited generalizability. It also had small sample sizes for some subgroups, which means more research may be particularly necessary in these subgroups. Since researchers did not test children or people taking immunosuppressants, more research is needed to see how well this testing method would work in these populations. Researchers also acknowledge an untested 'reproducibility across laboratories.' More research is thus needed before the WBAIL-2 assay can really be used in the clinical setting. Further, the authors did not examine the cost-effectiveness of the WBAIL-2 test and how well this would stack up against current ways of diagnosing celiac disease. Then, the test was not as accurate for some participants with a specific genotype, which means it might not work for everyone. However, the number of participants with this genotype was very small in this study, and it is possible that the level of interleukin-2 response of some participants with this genotype was just not able to be detected by the test. Overall, more research is required regarding this subtype of individuals and the use of this test. Ian Storch, DO, an osteopathic physician specializing in gastroenterology and internal medicine, and an American Osteopathic Association member, who was not involved in this study, spoke to Medical News Today about its findings. 'One limitation of this study is the poor performance in the DQ8 genetic arm, which makes up 10% of celiac patients. This will decrease the sensitivity and specificity for the control group or require HLA typing before the assay is run.' Researchers acknowledge that the serum analysis of interleukin-2 following a gluten challenge does not always line up with the results of the WBAIL-2 assay, which could have to do with the assays' differences. Shilpa Mehra Dang, MD, double board-certified in gastroenterology and internal medicine with Medical Offices of Manhattan and contributor to LabFinder, who was similarly not involved in this research, noted that 'we need to look at bigger samples to really see its clinical usefulness.' In addition to larger studies, research can also focus on more details regarding gluten-specific T cells. Celiac disease is a challenging condition to manage, and accurate diagnosis is important. Researchers suggest that examining WBAIL-2 and serum interleukin-2 after gluten consumption could allow people with celiac disease to not have to get biopsies done to confirm celiac diagnosis. The authors of this study also suggest that the WBAIL-2 assay could also become a first test among people following a gluten-free diet and help with symptom severity prediction. Storch said: 'I do not think that based on the data presented, removal of histology to confirm the diagnosis can be suggested.' Jeffrey D. Davis, DO, CMD, an osteopathic physician specializing in Family Medicine and Preventive Health and an American Osteopathic Association board member, who was not involved in the study, noted the following to MNT : 'I see potential for a commercially available rapid, simple, cost-effective laboratory test for physicians to use to assist in the accurate diagnosis of celiac disease. This study shows that especially in adults already on a gluten-free diet using this lab test versus currently available tests would improve our diagnostic capabilities for Celiac Disease. However, it would most likely be just another tool in our tool box to aid in the diagnosis along with other current diagnostic methods.'
Daily Mail
7 hours ago
- Daily Mail
Quintessential summer drink shockingly linked to aggressive skin cancer
Summer's here, which means millions will be enjoying a glass of wine on a warm evening. But scientists warn that the type of wine you drink could be raising your risk of skin cancer. A new study found that drinking white wine was associated with a 22 percent higher risk of melanomas and other forms of skin cancers compared to drinking red wine. One of the theories is that white wine is often consumed in the sun, which itself is a risk factor for skin cancer. Red wine also contains chemicals that have anti-inflammatory properties which some studies suggest could have a protective effect on cells. Eunyoung Cho, co-lead author of the study and associate professor of epidemiology and of dermatology at Brown University, said: 'We did observe a distinction when it came to skin cancer risk. 'Specifically, the consumption of white wine, but not red wine, was associated with an increased risk of skin cancer.' The American Cancer Society notes all alcohol consumption can lead to cancer and recommends limiting to one drink per day for women and two drinks per day for men. The group of researchers analyzed 42 studies with nearly 96,000 participants to compare the cancer risk caused by both red and white wine. Among the participants, the scientists identified those who drank the most and least white and red wine, respectively, and how much they consumed. Since the analysis pooled data from multiple research papers from across the world, each with its own definitions of consumption levels, it remains unclear how many glasses of wine each participant was drinking. While 'high' consumption usually means around one glass per day, this can vary from country to country. However, the data that was collected by the Brown University researchers was then measured using multiple statistical models to find a link between drinking wine and the probability of developing cancer. Results showed that women who drank white wine were at a greater risk of developing any kind cancer in their body as compared to men who drank white wine. The researchers did not find any link between red wine and skin cancer. It also remains unclear how many glasses of white wine can raise the risk of skin cancer. has reached to Dr Cho for more information. While Dr Cho and her team did not identify a clear reason on how white wine can increase the risk of cancer, they theorized that it was possible that women do not take protective measures against skin cancer when under the influence of alcohol. Skin cancer is usually caused due to a toxic growth of skin cells and can quickly spread across the skin. Normally, as skin cells grow old and die, new cells form to replace them. When this process stops to work as it should due to exposure to ultraviolet (UV) light from the sun, cells grow more quickly and become toxic. The most common form of skin cancer is basal cell carcinoma and squamous cell carcinoma - both of which can often be cured. Basal cell carcinoma is defined as the cancer that forms in your basal cells in the lower part of the outside layer of the skin while squamous cell carcinoma forms in the squamous cells in the outside layer of the skin. The most dangerous form of skin cancer is melanoma. It is more likely to spread, making it harder to cure. This type of skin cancer forms in cells called melanocytes. Melanocytes produce melanin, a brown pigment that gives your skin its color and protects against some of the sun's damaging UV rays. However, without proper protection such as using sunscreen, UV rays can damage melanocytes and pave the way for the development of melanoma. Previous studies have shown a statistically significant association between alcohol consumption and an increased risk of melanoma. According to Harvard Health, one study found that the risk of basal cell carcinoma increased by seven percent and squamous cell carcinoma increased by 11 percent for every 10-gram increase in intake of alcohol in distilled spirit form (or one standard beer or small glass of wine) each day. Another study also found a 20 percent increase in melanoma in drinkers (compared to those who don't drink alcohol or only drink occasionally) Additionally, it also found that those who drink 50-grams of alcohol (or five beers) per day had a 55 percent increase in risk for melanoma. Numerous researchers believe that drinking alcohol while basking in the sunlight can increase a person's risk of developing cancer. As you drink, the body begins to process and metabolize alcohol which leads to the formation of Acetaldehyde. Acetaldehyde is a known carcinogen - cancer causing substance - that is known to damage cell DNA and can increase a person's chances of having cancer. Coupled with the sun's UV rays that continue to damage the skin, the likelihood to develop the deadly illness increase. The American Cancer Society recommends limiting alcohol consumption to one drink per day for women and two drinks per day for men. But experts say that it is important to consider your underlying risk for developing skin cancer based on sun exposure and ethnicity and then alter your lifestyle.
The Independent
7 hours ago
- The Independent
This common nut can lower your risk of heart disease, dementia and diabetes
A handful of almonds each day could significantly reduce a condition that has been linked to heart disease, diabetes, and dementia, according to a new study in the journal Nutrition Research. Around one in three Americans are affected by metabolic syndrome, and evidence shows they are 'three times as likely to suffer a heart attack or stroke and twice as likely to die from coronary heart disease compared to people without this condition,' lead study author Emily Ho, director of the Linus Pauling Institute at Oregon State University, said in a statement released in the report. 'Poor diet and inactivity contribute to the development of metabolic syndrome, and gut health and chronic inflammation may also play roles,' she added. But swapping processed snacks for a handful of almonds – about 45 nuts – in your daily diet could help curb some of the most serious chronic health risks facing Americans today. In a 12-week clinical trial, researchers studied adults aged 35 to 60 who had been diagnosed with metabolic syndrome. One group consumed 320 calories of almonds daily while the other group ate the same number of calories from crackers. Those who ate almonds experienced significant health improvements, including reductions in total cholesterol, LDL (bad) cholesterol, and waist circumference. Blood tests also showed increased levels of vitamin E, an antioxidant known to reduce inflammation and support heart, nerve, and muscle function. Participants in the almond group also saw lower levels of gut inflammation — a promising sign, as maintaining a healthy gut microbiome is increasingly recognized as vital to long-term health. 'In addition to vitamin E, almonds have polyunsaturated and monounsaturated fats, fiber, polyphenols, biotin, copper, potassium and magnesium,' said study co-author Laura Beaver, a research associate in the Oregon State College of Health. 'The changes in cholesterol levels we observed suggest a meaningful metabolic shift in those who consumed almonds daily.' The findings align with previous research highlighting the health benefits of almonds.
